For healthcare professionals only


Comparing bivalent and quadrivalent HPV vaccines

BMJ 2011; 343 doi: (Published 19 October 2011) Cite this as: BMJ 2011;343:d6786

In the third paragraph from the end in this editorial by René H M Verheijen (BMJ 2011;343:d5720, doi:10.1136/bmj.d5720) the author mistakenly referred to deaths instead of cases. The fourth sentence should have read: “It has been estimated that the Italian programme, which uses the bivalent vaccine, would prevent 295 more cases of cancer [not “295 more deaths from cancer”] but 25 848 fewer cases of genital warts than if it used the quadrivalent vaccine.”


Cite this as: BMJ 2011;343:d6786

View Abstract